Didanosine - 65862-109-02 - (Didanosine)

Alphabetical Index


Drug Information of Didanosine

Product NDC: 65862-109
Proprietary Name: Didanosine
Non Proprietary Name: Didanosine
Active Ingredient(s): 10    mg/mL & nbsp;   Didanosine
Administration Route(s): ORAL
Dosage Form(s): POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Didanosine

Product NDC: 65862-109
Labeler Name: Aurobindo Pharma Limited
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA078112
Marketing Category: ANDA
Start Marketing Date: 20070308

Package Information of Didanosine

Package NDC: 65862-109-02
Package Description: 1 BOTTLE in 1 CARTON (65862-109-02) > 200 mL in 1 BOTTLE

NDC Information of Didanosine

NDC Code 65862-109-02
Proprietary Name Didanosine
Package Description 1 BOTTLE in 1 CARTON (65862-109-02) > 200 mL in 1 BOTTLE
Product NDC 65862-109
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Didanosine
Dosage Form Name POWDER, FOR SOLUTION
Route Name ORAL
Start Marketing Date 20070308
Marketing Category Name ANDA
Labeler Name Aurobindo Pharma Limited
Substance Name DIDANOSINE
Strength Number 10
Strength Unit mg/mL
Pharmaceutical Classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of Didanosine


General Information